Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06167369

Biological and Cognitive Marker of Neurodegeneration in Obstructive Sleep Apnea Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
136 (estimated)
Sponsor
Technische Universität Dresden · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to investigate biomarkers and neurocognitive markers of neurodegenerative processes in obstructive sleep apnea patients. The main questions the study aims to answer are: * Does neurodegeneration assessed by neurobiological markers and neurocognitive test performance exists in obstructive sleep apnea? * Are these neurodegenerative markers are associated with the adherence to clinical prescribed positive airway pressure therapy? Newly diagnosed patients with obstructive sleep apnea will be observed during the use of clinical prescribed positive pressure therapy. Different study related investigations take place before and six months after treatment start. Researchers will compare after six months the group of adherent treatment participants with the non-adherent treatment participants group to investigate if differences in the observed neurobiological or neurocognitive parameters exist.

Conditions

Timeline

Start date
2024-01-01
Primary completion
2025-12-31
Completion
2026-06-01
First posted
2023-12-12
Last updated
2024-02-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06167369. Inclusion in this directory is not an endorsement.

Biological and Cognitive Marker of Neurodegeneration in Obstructive Sleep Apnea Patients (NCT06167369) · Clinical Trials Directory